Antitumor Effects of Carnertinib in Castration Resistant Prostate Cancer Models: A Comparative Study With ErlotinibGRAVINA, Giovanni Luca; MARAMPON, Francesco; PICCOLELLA, Margherita et al.The Prostate. 2011, Vol 71, Num 14, pp 1481-1491, issn 0270-4137, 11 p.Article

Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer ModelsGRAVINA, Giovanni Luca; MARAMPON, Francesco; JANNINI, Emmanuele A et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 12, pp 4550-4561, issn 0013-7227, 12 p.Article

Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer modelsLUCA GRAVINA, Giovanni; MARAMPON, Francesco; GIUSTI, Ilaria et al.International journal of oncology. 2012, Vol 40, Num 3, pp 711-720, issn 1019-6439, 10 p.Article

5-Azacitidine Restores and Amplifies the Bicalutamide Response on Preclinical Models of Androgen Receptor Expressing or Deficient ProstateTumorsGRAVINA, Giovanni Luca; MARAMPON, Francesco; DI STASO, Mario et al.The Prostate. 2010, Vol 70, Num 11, pp 1166-1178, issn 0270-4137, 13 p.Article